262 related articles for article (PubMed ID: 16188001)
21. Diabetic macular edema.
Narula R; Agarwal M; Chaudhary SP; Shroff C
Ophthalmology; 2009 Sep; 116(9):1833-4; author reply 1834. PubMed ID: 19729104
[No Abstract] [Full Text] [Related]
22. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
Audren F; Erginay A; Haouchine B; Benosman R; Conrath J; Bergmann JF; Gaudric A; Massin P
Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
[TBL] [Abstract][Full Text] [Related]
23. Diabetic macular edema.
Kim SJ
Ophthalmology; 2009 Jun; 116(6):1228.e1; author reply 1228-9. PubMed ID: 19486803
[No Abstract] [Full Text] [Related]
24. Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.
Audren F; Lecleire-Collet A; Erginay A; Haouchine B; Benosman R; Bergmann JF; Gaudric A; Massin P
Am J Ophthalmol; 2006 Nov; 142(5):794-99. PubMed ID: 16978576
[TBL] [Abstract][Full Text] [Related]
25. Laser photocoagulation combined with subtenon injection of triamcinolone acetonide for diabetic cystoid macular edema.
Kuo HK; Wu PC; Chen YH; Cheng LS
Chang Gung Med J; 2009; 32(2):172-81. PubMed ID: 19403007
[TBL] [Abstract][Full Text] [Related]
26. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Ho TC; Lai WW; Lam DS
Am J Ophthalmol; 2006 Apr; 141(4):786-7; author reply 787-8. PubMed ID: 16564847
[No Abstract] [Full Text] [Related]
28. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Sarici A; Muftuoglu G
Am J Ophthalmol; 2006 Apr; 141(4):785-6; author reply 786. PubMed ID: 16564845
[No Abstract] [Full Text] [Related]
29. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
Browning DJ; Fraser CM; Powers ME
Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833
[TBL] [Abstract][Full Text] [Related]
31. DRCR Study: outcomes in focal vs diffuse edema?
Blanco-Garavito R; Rodriguez-Valdes PJ
Ophthalmology; 2009 Mar; 116(3):595-6; author reply 596-7. PubMed ID: 19264221
[No Abstract] [Full Text] [Related]
32. The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema.
Soliman W; Sander B; Soliman KA; Yehya S; Rahamn MS; Larsen M
Acta Ophthalmol; 2008 May; 86(3):284-91. PubMed ID: 18005220
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
[TBL] [Abstract][Full Text] [Related]
34. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
[TBL] [Abstract][Full Text] [Related]
35. Correspondence.
Lorenzo-Carrero J
Retina; 2009 Jun; 29(6):868-9; author reply 869. PubMed ID: 19516126
[No Abstract] [Full Text] [Related]
36. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide.
Saraiva VS; Sallum JM; Farah ME
Ophthalmic Surg Lasers Imaging; 2003; 34(5):398-400. PubMed ID: 14509465
[TBL] [Abstract][Full Text] [Related]
37. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema.
Zein WM; Noureddin BN; Jurdi FA; Schakal A; Bashshur ZF
Retina; 2006 Feb; 26(2):137-42. PubMed ID: 16467667
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
39. Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy.
Bandello F; Polito A; Pognuz DR; Monaco P; Dimastrogiovanni A; Paissios J
Arch Ophthalmol; 2006 May; 124(5):643-50. PubMed ID: 16682585
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial.
Gillies MC; McAllister IL; Zhu M; Wong W; Louis D; Arnold JJ; Wong TY
Ophthalmology; 2011 May; 118(5):866-72. PubMed ID: 21232801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]